Gilead Sciences to Quadruple Production of Cell Therapy Cancer Treatments by 2026

Healthcare News

Gilead Sciences to Quadruple Production of Cell Therapy Cancer Treatments by 2026
Gilead SciencesCell TherapyCancer Treatments
  • 📰 Medscape
  • ⏱ Reading Time:
  • 36 sec. here
  • 7 min. at publisher
  • 📊 Quality Score:
  • News: 35%
  • Publisher: 55%

Gilead Sciences will be able to quadruple production of its cell therapy cancer treatments by 2026 due to improvements in the U.S. biotech's manufacturing processes, an...

Receive email when new articles are published onFREDERICK, Maryland - Gilead Sciences will be able to quadruple production of its cell therapy cancer treatments by 2026 due to improvements in the U.S. biotech's manufacturing processes , an executive in charge of that business told Reuters.

Cell therapies like its chimeric antigen receptor T-cell treatments Yescarta and Tecartus are increasingly important to Gilead, which has been working for several years to build its presence in oncology and diversify outside of its core HIV business. CAR-T therapy involves removing a patients’ own T cells - a key component of the immune system - engineering them to recognize and attack malignant cells, and re-infusing them.

Gilead is expanding its network of health center sites across the U.S. where patients can receive the therapy, and "doubling down" on efforts to reach patients in its existing treatment sites in academic hospitals around the country, Perettie said.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

Medscape /  🏆 386. in US

Gilead Sciences Cell Therapy Cancer Treatments Manufacturing Processes Capacity Increase

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Gilead CAR-T Cancer Therapy Capacity to Quadruple by 2026Gilead CAR-T Cancer Therapy Capacity to Quadruple by 2026Gilead Sciences will be able to quadruple production of its cell therapy cancer treatments by 2026 due to improvements in the U.S. biotech's manufacturing processes, an...
Read more »

With Hollywood Calling, Kountry Wayne Vows His Current Comedy Tour Will Be His Last ‘Until 2026’With Hollywood Calling, Kountry Wayne Vows His Current Comedy Tour Will Be His Last ‘Until 2026’Kountry Wayne has not stopped his rise in the world of stand-up, and the smooth talking southerner is leaving it all on the stage with his latest King of Hearts tour, kicking off its national run in Houston at 713 Music Hall on March 15. “Houston kicks it off for...
Read more »

2024 Nissan GT-R, 2026 BMW iX3: Today's Car News2024 Nissan GT-R, 2026 BMW iX3: Today's Car NewsNissan GT-R special editions, BMW's first Neue Klasse SUV, and a Nissan and Honda tie-up all made headlines today.
Read more »

Ken Paxton, John Cornyn clash may foreshadow election fight in 2026Ken Paxton, John Cornyn clash may foreshadow election fight in 2026Criticism by Texas Attorney General Ken Paxton indicates that he is considering a challenge to U.S. Sen. John Cornyn in the 2026 Republican primary.
Read more »

2026 BMW iX3, i3 the next phase of BMW's electric shift | Car News2026 BMW iX3, i3 the next phase of BMW's electric shift | Car NewsThe next phase of BMW's electric shift comes via the iX3 SUV and i3 sedan, both set to debut around 2025-2026. Auto123 has details.
Read more »

EPA tells Terumo plant in Lakewood to slash emissions of cancer-causing gas by 2026EPA tells Terumo plant in Lakewood to slash emissions of cancer-causing gas by 2026In 2022, the EPA announced it was studying ethylene oxide emissions and how they cause elevated cancer risk, and the federal agency identified Terumo’s Lakewood location as a facility where cancer …
Read more »



Render Time: 2025-02-21 09:11:09